Sino Medical Sciences Technology Inc., (SHA: 688108), a Chinese medical device company, has announced that it has received market approval in Bangladesh for its HT Supreme drug-eluting stent system. The system is designed to improve the diameter of the coronary artery lumen in patients with symptomatic heart disease caused by primary coronary artery lesions, with a length of up to 40mm and a reference vessel diameter of 2.25-5.00mm. Prior to this, the product had already been registered in Taiwan, India, Uzbekistan, and Brazil.
The HT Supreme drug-coated coronary artery stent system is a drug-device combination product, comprising a drug-coated expandable cobalt chromium (CoCr) alloy coronary artery stent and a balloon delivery system. The stent’s base is coated with a non-corrosive polymer layer, and the surface is further coated with a biodegradable polymer layer for drug release. The drug release mechanism involves a mixture of sirolimus and biodegradable polymers, utilizing a rapid exchange balloon expandable conveying system to deploy the stent.- Flcube.com
